The Philadelphia Fed saw its primary gauge measuring the sector jump from 0.3 in June to 21.8, far better than Wall Street estimates of 5 and the highest in a year.Economyread more
Stocks fell for a third straight day on Thursday as Wall Street digested a mixed batch of corporate earnings results.US Marketsread more
It's tempting to view Netflix as a possible replacement for the entire media ecosystem. But execs on its Q2 earnings call showed lower ambitions: It just wants to create the...Technologyread more
Hacker Square at Facebook's headquarters features large gray stripes that are an homage to an early event in the company's history that epitomized the company's spirit of move...Technologyread more
These are the stocks posting the largest moves midday.Market Insiderread more
Jeffrey Epstein, a former friend of Presidents Donald Trump and Bill Clinton, had asked a judge to release him on a bond of as high as $100 million or more.Politicsread more
Netflix blames its content slate, regional price increases and a "pull-forward effect" of its strong Q1 growth for the miss.Technologyread more
Nancy Pelosi and House Democrats contend the $15 per hour minimum wage bill will lift workers who have not seen the benefits of a strong economy.Politicsread more
The strengthening of the president's formidable campaign war chest has led his organization, along with the Republican National Committee, to raise over $100 million in the...2020 Electionsread more
Treasury Secretary Steven Mnuchin says if the call goes well, he would expect in-person meetings to take place.Marketsread more
The filing came a day after the judge in Michael Cohen's criminal case ordered their release, saying that the end of a probe into those payments to alleged sexual partners of...Politicsread more
Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
The Centers for Disease Control said a patient being treated at a hospital in Dallas tested positive for the disease.
Ebola is believed to have sickened more than 6,500 people in West Africa, and more than 3,000 people have died.
The World Health Organization has worked to speed up the use of some experimental vaccines and companies are ramping up testing. Earlier this month NewLink Genetics said it would start safety testing of a vaccine within a few weeks, while Inovio Pharmaceuticals said it would start human trials of a DNA-based vaccine in early 2015.
Shares of Inovio Pharmaceuticals shares rose 35 cents, or 3.6 percent, to $10.20 in aftermarket trading, while NewLink Genetics shares gained $2.68, or 12.5 percent, to $24.10. Stock of some other companies that have been involved in efforts to come up with vaccines and medications also jumped. BioCryst Pharmaceuticals added $1.26, or 13 percent, to $11.04; Sarepta Therapeutics rose $1.57, or 7.4 percent, to $22.67; and Tekmira Pharmaceuticals stock climbed $5.97, or 28 percent, to $27.11.
Ebola's symptoms can start as much as 21 days after exposure, and the disease isn't contagious until symptoms begin. It takes close contact with bodily fluids to spread.